NDC 69412-001 Royal King Pain Relief Patch
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 69412 - Tianshui Weishi Tongtai Pharmaceutical Co Ltd
- 69412-001 - Royal King Pain Relief Patch
Product Packages
NDC Code 69412-001-03
Package Description: 3 PATCH in 1 BOX / 7.9 g in 1 PATCH
Product Details
What is NDC 69412-001?
What are the uses for Royal King Pain Relief Patch?
Which are Royal King Pain Relief Patch UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)
- CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET) (Active Moiety)
Which are Royal King Pain Relief Patch Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LANOLIN (UNII: 7EV65EAW6H)
- LIGUSTICUM WALLICHII ROOT (UNII: R81AD159QS)
- CURCUMA ZEDOARIA LEAF (UNII: M9E9LQH7N4)
- GARDENIA JASMINOIDES FLOWER (UNII: 2TU49609L2)
- RHEUM OFFICINALE ROOT (UNII: A47JP5ZG9M)
- ASPERAGENIN (UNII: 56JLP9B53W)
- PAWPAW (UNII: 8P95FP65YO)
- FRANKINCENSE (UNII: R9XLF1R1WM)
- MYRRH (UNII: JC71GJ1F3L)
What is the NDC to RxNorm Crosswalk for Royal King Pain Relief Patch?
- RxCUI: 1866042 - camphor 0.13 % Medicated Patch
- RxCUI: 1866042 - camphor 0.0013 MG/MG Medicated Patch
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".